1. Home
  2. IDN vs ANIX Comparison

IDN vs ANIX Comparison

Compare IDN & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$3.65

Market Cap

73.5M

Sector

Technology

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.72

Market Cap

108.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDN
ANIX
Founded
1994
1982
Country
United States
United States
Employees
38
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.5M
108.5M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
IDN
ANIX
Price
$3.65
$3.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$7.33
$8.67
AVG Volume (30 Days)
320.1K
312.4K
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
12.82
EPS
0.03
N/A
Revenue
$4,433,454.00
$210,000.00
Revenue This Year
$12.54
N/A
Revenue Next Year
$15.32
N/A
P/E Ratio
$122.33
N/A
Revenue Growth
23.21
N/A
52 Week Low
$3.61
$2.32
52 Week High
$9.08
$5.46

Technical Indicators

Market Signals
Indicator
IDN
ANIX
Relative Strength Index (RSI) 30.64 68.10
Support Level N/A $2.48
Resistance Level $4.49 $4.52
Average True Range (ATR) 0.15 0.27
MACD -0.01 0.05
Stochastic Oscillator 8.44 84.31

Price Performance

Historical Comparison
IDN
ANIX

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: